Results 171 to 180 of about 175,228 (263)

Biogas purification and enrichment: sustainability metrics analysis of dry anaerobic digester with cashew apple bagasse substrate

open access: yesBiofuels, Bioproducts and Biorefining, EarlyView.
Abstract This study hypothesizes that cashew apple bagasse‐based anaerobic digestion, combined with biochar purification, enhances biogas quality and sustainability. This study aims to investigate the performance and sustainability of a biochar‐based biogas purification technology using cashew apple bagasse as a substrate, with a focus on environmental
Priscila Marchiori   +5 more
wiley   +1 more source

Circular economy assessment of biomethane value chain in Brazil

open access: yesBiofuels, Bioproducts and Biorefining, EarlyView.
Abstract From the numerous opportunities to add value to biomass in Brazil, biomethane production in sugarcane mills presents significant potential. This study introduces a diagnostic framework grounded in circular economy (CE) principles to assess new biomethane projects, aligning with the strategic objectives of product diversification, full biomass ...
Luciana Fonseca Moreira   +3 more
wiley   +1 more source

Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova   +5 more
wiley   +1 more source

Possible therapeutic repositioning of valproic acid: From epileptic seizures to acute kidney injury

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Valproic acid, an anticonvulsant, may be repositioned to prevent acute kidney injury due to ischemia followed by reperfusion. It preserves renal functions, electrolyte homeostasis and active sodium transport in kidney tubules, and blocks the onset of hypertension.
Danilo Alves‐Bezerra   +8 more
wiley   +1 more source

Metabolomic investigation of cisplatin‐induced acute kidney injury in paediatric cancer patients

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim Cisplatin causes acute kidney injury (AKI) in approximately 46% of paediatric cancer patients who receive it. Serum creatinine (SCr) is a poor biomarker of cisplatin nephrotoxicity, because there is a delay between cisplatin infusion and SCr elevation.
Yong Jin Lim   +37 more
wiley   +1 more source

Home - About - Disclaimer - Privacy